$74.70
1.41% yesterday
NYSE, May 20, 10:10 pm CET
ISIN
US83444M1018
Symbol
SOLV
Index
Sector

Solventum Stock price

$74.70
+10.76 16.83% 1M
+6.31 9.23% 6M
+8.64 13.08% YTD
+12.67 20.43% 1Y
-5.30 6.63% 3Y
-5.30 6.63% 5Y
-5.30 6.63% 10Y
NYSE, Closing price Tue, May 20 2025
-1.07 1.41%
ISIN
US83444M1018
Symbol
SOLV
Index
Sector

Key metrics

Market capitalization $12.92b
Enterprise Value $20.66b
P/E (TTM) P/E ratio 34.42
EV/FCF (TTM) EV/FCF 52.84
EV/Sales (TTM) EV/Sales 2.49
P/S ratio (TTM) P/S ratio 1.56
P/B ratio (TTM) P/B ratio 3.96
Revenue growth (TTM) Revenue growth 1.28%
Revenue (TTM) Revenue $8.31b
EBIT (operating result TTM) EBIT $886.00m
Free Cash Flow (TTM) Free Cash Flow $391.00m
Cash position $534.00m
EPS (TTM) EPS $2.17
P/E forward 20.03
P/S forward 1.53
EV/Sales forward 2.45
Short interest 2.98%
Show more

Is Solventum a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Solventum Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Solventum forecast:

2x Buy
17%
9x Hold
75%
1x Sell
8%

Analyst Opinions

12 Analysts have issued a Solventum forecast:

Buy
17%
Hold
75%
Sell
8%

Financial data from Solventum

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
8,307 8,307
1% 1%
100%
- Direct Costs 3,701 3,701
7% 7%
45%
4,606 4,606
3% 3%
55%
- Selling and Administrative Expenses 2,407 2,407
41% 41%
29%
- Research and Development Expense 770 770
2% 2%
9%
1,429 1,429
37% 37%
17%
- Depreciation and Amortization 543 543
2% 2%
7%
EBIT (Operating Income) EBIT 886 886
48% 48%
11%
Net Profit 378 378
71% 71%
5%

In millions USD.

Don't miss a Thing! We will send you all news about Solventum directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Solventum Stock News

Neutral
Seeking Alpha
9 days ago
Solventum Corporation (NYSE:SOLV ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Amy Wakeham - Senior Vice President of Investor Relations & External Finance Communications Bryan Hanson - Chief Executive Officer Wayde McMillan - Chief Financial Officer Conference Call Participants Patrick Wood - Morgan Stanley Frederick Wise - Stifel, Nicolaus & Company, Inc. Jaso...
Positive
Seeking Alpha
12 days ago
Solventum Corporation's stock has dropped 20% since February despite beating earnings and revenue expectations in its last two quarterly reports. SOLV operates in four divisions: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration, with a market cap of $11.5 billion. The company recently announced the sale of its Purification and Filtration business to Thermo ...
Positive
Reuters
12 days ago
3M spin-off Solventum beat analysts' estimate for first-quarter profit on Thursday, helped by higher sales of its wound care, sterilization products.
More Solventum News

Company Profile

Solventum Corp. operates as a health care company. The company was founded on January 24, 2023 and is headquartered in Maplewood, MN.

Head office United States
CEO Bryan Hanson
Employees 22,000
Website www.solventum.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today